Recent Progress in Affinity Sensing for Advanced Healthcare Applications

Biomolecular sensing has shown remarkable potential in offering detailed insights into the healtcare monitoring. By detecting specific biomolecules, these sensors enable early diagnosis and monitoring of diseases, support precision farming, and improve veterinary care. They provide real-time, in-situ measurements, transforming health and disease management across various fields and making advanced diagnostics accessible in remote and resource-limited areas. Recent advancements in miniaturized affinity sensing, new catalytic tags, various signal amplification strategies, and the introduction of novel molecular agents (such as oligonucleotides, nanobodies, natural cell membrane receptors, and molecularly-imprinted polymers) have propelled the development of simplified devices for decentralized applications. These innovative devices, equipped with novel transducing elements and analytical approaches, enable point-of-care and real-time monitoring of various analytes in humans, plants, and animals, even in remote areas and household settings. This symposium invites emerging research in the field of affinity sensing technologies, emphasizing cross-disciplinary knowledge integration for in-situ biomolecular detection. Aiming to minimize disease progression globally, this interdisciplinary symposium will bring together leading experts employing novel analytical approaches to address these challenges and foster the development of future miniaturized technologies for decentralized healthcare monitoring.